These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Mavrogeni S; Sfikakis PP; Gialafos E; Bratis K; Karabela G; Stavropoulos E; Spiliotis G; Sfendouraki E; Panopoulos S; Bournia V; Kolovou G; Kitas GD Arthritis Care Res (Hoboken); 2014 Jan; 66(1):104-12. PubMed ID: 24106233 [TBL] [Abstract][Full Text] [Related]
23. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements. Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403 [TBL] [Abstract][Full Text] [Related]
25. Vasculitis associated with connective tissue diseases. Cozzani E; Gasparini G; Papini M; Burlando M; Drago F; Parodi A G Ital Dermatol Venereol; 2015 Apr; 150(2):221-32. PubMed ID: 25732106 [TBL] [Abstract][Full Text] [Related]
26. Pain in systemic inflammatory rheumatic diseases. Atzeni F; Masala IF; Salaffi F; Di Franco M; Casale R; Sarzi-Puttini P Best Pract Res Clin Rheumatol; 2015 Feb; 29(1):42-52. PubMed ID: 26266998 [TBL] [Abstract][Full Text] [Related]
27. [Septic arthritis in connective tissue diseases and other chronic arthropathies]. Stecher DR; Gusis SE; Maldonado Cocco JA Medicina (B Aires); 1991; 51(3):238-40. PubMed ID: 1821907 [TBL] [Abstract][Full Text] [Related]
29. Overlap connective tissue disease syndromes. Iaccarino L; Gatto M; Bettio S; Caso F; Rampudda M; Zen M; Ghirardello A; Punzi L; Doria A Autoimmun Rev; 2013 Jan; 12(3):363-73. PubMed ID: 22743033 [TBL] [Abstract][Full Text] [Related]
30. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? de Lauretis A; Veeraraghavan S; Renzoni E Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375 [TBL] [Abstract][Full Text] [Related]
33. [Proposal of a questionnaire for the characterization of the prevalence of digestive symptoms in connective tissue diseases]. Machado WM; Freire BF; Rocha OM; Azambuja CA; Oliveira ME Arq Gastroenterol; 2004; 41(1):64-70. PubMed ID: 15499428 [TBL] [Abstract][Full Text] [Related]
34. [Interstitial lung disease in connective tissue diseases]. Duxbury B; Rochat T Rev Med Suisse; 2015 Nov; 11(495):2170-2, 2174-5. PubMed ID: 26742238 [TBL] [Abstract][Full Text] [Related]
35. Clinical applicability of quantitative nailfold capillaroscopy in differential diagnosis of connective tissue diseases with Raynaud's phenomenon. Wu PC; Huang MN; Kuo YM; Hsieh SC; Yu CL J Formos Med Assoc; 2013 Aug; 112(8):482-8. PubMed ID: 24016612 [TBL] [Abstract][Full Text] [Related]